Examples include the BCR::ABL1 gene fusion in patients with CML [2] and ALK fusions (e.g. EML4::ALK) in non-small-cell lung cancer [9]. The gene discussed is ALK; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.